Cognizant Technology Solutions
CTSH
$64.10
+6.83%
Cognizant Technology Solutions is a multinational IT services and consulting provider offering digital transformation, business process outsourcing, and technology consulting to enterprise clients across financial services, healthcare, communications, media, technology, and resources industries. With approximately 356,700 employees and a global delivery model heavily weighted toward offshore operations in India, Cognizant competes as a top-tier challenger to Accenture, Infosys, and TCS in the global IT services market, distinguished by its deep vertical specialization and U.S. headquarters advantage. The current investor narrative centers on whether Cognizant can sustain mid-single-digit revenue growth and margin expansion amid a challenging IT spending environment, with the stock having experienced a severe drawdown from its 52-week high of $87.03 to a low of $37.08 before staging a notable recovery. Recent quarterly results showing 5.83% year-over-year revenue growth and improving profitability have reignited debate about whether the company's AI-driven service offerings and large deal wins can offset pricing pressure and discretionary spending softness in key verticals.…
CTSH
Cognizant Technology Solutions
$64.10
Related headlines
Investment Opinion: Should I buy CTSH Today?
We assign a Hold rating on Cognizant Technology Solutions (CTSH). The core thesis is that the stock is deeply undervalued on a forward earnings basis (forward PE of 9.49x) but faces near-term margin pressures and competitive headwinds that limit upside until there is clearer evidence of sustainable growth. The analyst consensus rating of 'buy' (mean 2.21) and average target price of $64.18 imply a modest 6.97% upside, suggesting the market has already priced in much of the recovery. While the fortress balance sheet and consistent profitability are attractive, the risk/reward is balanced at current levels.
The supporting evidence for a Hold is compelling: Cognizant trades at a significant discount to the broader IT services sector, with a price-to-sales ratio of 1.89x and EV-to-EBITDA of 9.49x, both below sector medians. Revenue grew 5.83% YoY in Q1 2026, and net income was $662 million, yielding a healthy 12.23% net margin. The company generates robust TTM free cash flow of $2.47 billion and returns capital via a 1.53% dividend yield and $444 million in Q1 2026 buybacks. However, gross margin compression from 33.87% to 29.63% over two quarters is a red flag that could pressure future earnings. The forward PE of 9.49x implies the market expects EPS to more than double to $6.26, a lofty assumption given margin headwinds.
The biggest risks that could invalidate the Hold rating include: (1) continued gross margin deterioration below 28%, which would likely trigger downward EPS revisions and multiple compression; (2) a slowdown in IT spending that reduces revenue growth to low single digits; and (3) competitive share loss to larger peers like Accenture. The rating would upgrade to Buy if gross margins stabilize above 30% and revenue growth accelerates above 7%, or if the stock pulls back to the $50-$52 support zone. Conversely, a downgrade to Sell would occur if gross margins fall below 28% or if revenue growth decelerates below 4%. Relative to its own history, the stock is undervalued (PS ratio near multi-year lows), but fairly valued relative to peers given its growth profile. The valuation verdict is undervalued on a forward basis but with high uncertainty.
Sign up to view all
CTSH 12-Month Price Forecast
Cognizant presents a balanced risk/reward profile with a neutral stance. The stock is deeply undervalued on a forward earnings basis, but the market is pricing in a significant earnings recovery that hinges on margin stabilization. The company's strong balance sheet and consistent cash flow generation provide a margin of safety, but the recent gross margin deterioration and competitive pressures are concerning. Analyst sentiment is moderately bullish, but the wide target range reflects uncertainty. We would upgrade to bullish if gross margins stabilize above 31% and revenue growth accelerates above 7%, or downgrade to bearish if margins fall below 28% or revenue growth decelerates below 4%. The key monitorable is the gross margin trajectory in the next two quarters.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cognizant Technology Solutions's 12-month outlook, with a consensus price target around $64.18 and implied upside of +0.1% versus the current price.
Average Target
$64.18
0 analysts
Implied Upside
+0.1%
vs. current price
Analyst Count
—
covering this stock
Price Range
$42 - $84
Analyst target range
Cognizant is covered by 25 analysts with a consensus recommendation of "buy" and a recommendation mean of 2.21 (where 1 is strong buy and 5 is strong sell), indicating a moderately bullish stance. The average target price of $64.18 implies approximately 6.97% upside from the current price of $60.00, suggesting analysts see modest appreciation potential but not dramatic upside. The consensus EPS estimate of $6.26 for the forward period, with a range of $6.15 to $6.37, reflects confidence in earnings growth, while the estimated revenue average of $24.74 billion (range: $24.41 billion to $25.09 billion) implies low-to-mid single-digit growth expectations. The consensus leans moderately bullish, though the relatively modest upside to the average target suggests analysts believe much of the recovery is already priced in. The target price range spans from a low of $42.00 to a high of $84.00, representing a wide spread of 100% between the low and high targets, which signals significant disagreement among analysts about Cognizant's prospects. The high target of $84.00 implies roughly 40% upside and would require either multiple expansion, accelerating revenue growth, successful AI-driven service differentiation, or significant margin improvement to justify. The low target of $42.00 implies approximately 30% downside and likely prices in margin compression, competitive share loss, or a broader IT spending recession that would pressure both revenue and profitability. Recent institutional ratings show a mix of neutral and positive actions, with Wedbush upgrading to Outperform from Neutral in June 2026, while Citigroup, Baird, TD Cowen, and Morgan Stanley maintained neutral or hold-equivalent ratings. The wide target spread combined with the predominance of neutral ratings suggests analysts are in a wait-and-see mode, looking for evidence that Cognizant's growth and margin trajectory can sustainably improve before turning more constructive.
Drowning in data?
Find the real signal!
Bulls vs Bears: CTSH Investment Factors
The bull case rests on Cognizant's deep value (forward PE of 9.49x), fortress balance sheet (D/E of 0.105), and consistent profitability (net margin 12.23%), which collectively suggest the stock is oversold and poised for a re-rating as earnings recover. However, the bear case is equally compelling: gross margin compression (from 33.87% to 29.63%), severe relative underperformance (-31.17% vs. S&P 500 over 1 year), and a wide analyst target spread ($42-$84) highlight significant risks. Currently, the bear evidence appears stronger because the margin deterioration directly threatens the earnings growth needed to justify the forward PE gap, and the stock's technical recovery remains nascent. The single most important tension is whether Cognizant can stabilize and expand gross margins; if it does, the forward PE of 9.49x is a steal, but if margins continue to erode, the low target of $42 could be tested.
Bullish
- Deep Value on Forward Earnings: CTSH trades at a forward PE of just 9.49x versus a trailing PE of 18.20x, implying the market expects EPS to more than double to the consensus estimate of $6.26. This extreme gap suggests the stock is pricing in a severe earnings decline that may not materialize, creating a potential value opportunity if estimates prove conservative.
- Fortress Balance Sheet with Minimal Debt: The debt-to-equity ratio is only 0.105, the current ratio is 2.34, and interest coverage is 116.7x, providing immense financial flexibility. This allows Cognizant to continue funding acquisitions, dividends, and buybacks without balance sheet stress, even in a downturn.
- Consistent Revenue Growth and Profitability: Q1 2026 revenue grew 5.83% YoY to $5.413 billion, with net income of $662 million and a net margin of 12.23%. The company has demonstrated steady sequential revenue improvement over the past six quarters, showcasing resilience in a tough IT spending environment.
- Analyst Consensus Buy with Modest Upside: 25 analysts rate the stock a 'buy' with a mean recommendation of 2.21 and an average target price of $64.18, implying 6.97% upside. The high target of $84.00 suggests significant potential if growth accelerates or margins expand.
Bearish
- Gross Margin Compression Threatens Earnings: Gross margin has declined from 33.87% in Q3 2025 to 29.63% in Q1 2026, a 424 basis point drop over two quarters. If this trend continues, it could significantly pressure earnings and undermine the forward EPS estimates that justify the current valuation.
- Severe Underperformance and High Volatility: CTSH is down 14.95% over the past year and 26.18% YTD, vastly underperforming the S&P 500's 16.22% and 12.08% gains, respectively. The maximum drawdown of -55.33% highlights the stock's vulnerability to sharp declines, and the beta of 0.83 offers only modest downside protection.
- Wide Analyst Target Spread Signals Uncertainty: The target price range spans from $42.00 to $84.00, a 100% difference, indicating deep disagreement among analysts. The low target implies 30% downside, reflecting concerns about margin erosion, competitive pressures, or a broader IT spending slowdown.
- Modest Growth Lags Digital-Native Competitors: Revenue growth of 5.83% YoY is respectable for a large-cap but trails faster-growing peers. This suggests Cognizant is winning on cost and delivery rather than innovation, which may limit its ability to command premium multiples and sustain long-term growth.
CTSH Technical Analysis
Cognizant is in a recovery phase following a severe downtrend, with the stock down 14.95% over the past year but having rallied 15.01% over the past three months. The current price of $60.00 sits at approximately 45.9% of the 52-week range ($37.08 low to $87.03 high), indicating the stock has recovered substantially from its lows but remains far below its highs, suggesting the market is still pricing in meaningful uncertainty about the company's growth trajectory. The 1-year decline of 14.95% contrasts sharply with the S&P 500's 16.22% gain over the same period, resulting in a relative strength of -31.17%, underscoring significant underperformance that the recent rally has only partially reversed. Short-term momentum has turned positive, with a 1-month gain of 3.09% and a 3-month gain of 15.01%, both outpacing the S&P 500's respective returns of -1.06% and 3.04%, yielding positive relative strength readings of 4.15% and 11.97%. However, the 6-month change of -0.61% and year-to-date decline of -26.18% reveal that the recovery is still nascent and the stock remains deeply underwater for the year, with the recent pullback from the August high of $64.64 to $60.00 suggesting some momentum deceleration. The divergence between the strong 3-month performance and the negative 1-year and YTD trends signals a potential trend reversal in progress, though the stock needs to sustain above key levels to confirm. Key technical support is established at the 52-week low of $37.08, with intermediate support likely around the $50-$52 zone where the stock consolidated in May and June, while resistance is positioned at the 52-week high of $87.03, with nearer resistance around the August peak of $64.64. A breakout above $64.64 would signal renewed bullish conviction and could open a path toward the $70-$75 range, while a breakdown below $50 would undermine the recovery thesis and potentially retest the lows. With a beta of 0.83, Cognizant is approximately 17% less volatile than the broader market, which is typical for large-cap IT services firms and suggests the stock may offer relative downside protection but could also lag in strong market rallies. The maximum drawdown of -55.33% over the period highlights the severity of the prior decline and the magnitude of the recovery still needed to reach prior highs.
Beta
0.83
0.83x market volatility
Max Drawdown
-55.3%
Largest decline past year
52-Week Range
$37-$87
Price range past year
Annual Return
-7.3%
Cumulative gain past year
| Period | CTSH Return | S&P 500 |
|---|---|---|
| 1m | +9.0% | -2.0% |
| 3m | +25.6% | +1.4% |
| 6m | +6.3% | +15.0% |
| 1y | -7.3% | +15.7% |
| ytd | -21.1% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CTSH Fundamental Analysis
Cognizant's revenue trajectory shows steady but modest growth, with Q1 2026 revenue of $5.413 billion representing 5.83% year-over-year growth from Q1 2025's $5.115 billion. The multi-quarter trend reveals consistent sequential improvement, with revenue rising from $5.082 billion in Q4 2024 to $5.115 billion in Q1 2025, $5.245 billion in Q2 2025, $5.415 billion in Q3 2025, $5.333 billion in Q4 2025, and $5.413 billion in Q1 2026, demonstrating resilience despite a challenging IT spending environment. By segment, Financial Services is the largest contributor at $1.644 billion, followed by Healthcare at $1.579 billion, Products and Resources at $1.321 billion, and Communication, Media and Technology at $869 million, with the healthcare and financial services verticals likely driving growth given their digital transformation priorities. The growth rate in the mid-single digits is respectable for a company of Cognizant's scale but lags the faster-growing digital-native competitors, suggesting the company is winning on cost and delivery rather than innovation leadership. Profitability remains solid, with Q1 2026 net income of $662 million on revenue of $5.413 billion, yielding a net margin of 12.23%, and a gross margin of 29.63%. However, gross margin has compressed from 33.87% in Q3 2025 and 31.11% in Q4 2025 to 29.63% in Q1 2026, a trend that warrants monitoring as it could reflect pricing pressure, wage inflation, or mix shift toward lower-margin services. Operating income of $817 million in Q1 2026 represents a 15.09% operating margin, down from 15.99% in Q4 2025 and 16.68% in Q1 2025, indicating some margin erosion that may be seasonal or structural. The company's net margin of 12.23% is healthy for the IT services industry, though the sequential decline in gross margin from 33.87% to 29.63% over two quarters is a concern that could pressure earnings if sustained. Cognizant maintains a fortress-like balance sheet with a debt-to-equity ratio of just 0.105, a current ratio of 2.34, and a quick ratio of 2.23, providing substantial financial flexibility. Free cash flow on a trailing twelve-month basis stands at $2.47 billion, though Q1 2026 free cash flow was only $198 million due to a $730 million acquisition and $705 million working capital outflow, reflecting the seasonal nature of cash generation. Return on equity of 14.85% and return on assets of 10.74% demonstrate efficient capital deployment, while the interest coverage ratio of 116.7x underscores the company's minimal debt burden. The dividend payout ratio of 27.35% with a dividend yield of 1.53% indicates a shareholder-friendly capital allocation policy balanced with reinvestment needs, and the company repurchased $444 million of stock in Q1 2026, signaling confidence in its own valuation.
Quarterly Revenue
$5.4B
2026-03
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
29.6%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CTSH Overvalued?
With positive net income of $662 million in Q1 2026 and trailing twelve-month earnings, the PE ratio is the appropriate primary valuation metric for Cognizant. The trailing PE of 18.20x compares to a forward PE of just 9.49x, implying the market expects significant earnings growth ahead, with consensus EPS estimates of $6.26 for the forward period versus the current trailing EPS of approximately $3.30. This wide gap between trailing and forward PE suggests the market is pricing in a substantial earnings recovery, potentially driven by margin expansion, revenue acceleration, or one-time items rolling off. The PEG ratio of 20.57 appears anomalously high, likely reflecting the depressed trailing earnings base rather than a genuine growth premium, and should be interpreted with caution. Comparing Cognizant's valuation to the broader IT services sector, the trailing PE of 18.20x is modest relative to many technology peers, though the forward PE of 9.49x represents a significant discount to the sector average. The price-to-sales ratio of 1.89x and EV-to-sales of 1.26x are notably low for a company with Cognizant's scale and profitability, suggesting the market is pricing in limited growth expectations or margin concerns. The price-to-book ratio of 2.66x is reasonable given the company's 14.85% ROE, and the EV-to-EBITDA of 9.49x is below the sector median, indicating the stock may be undervalued relative to its cash generation capabilities. The dividend yield of 1.53% provides modest income support and is well-covered by the 27.35% payout ratio. Historically, Cognizant's PE ratio has ranged from a low of 11.03x in Q1 2026 to a high of 29.94x in Q3 2025, with the current 18.20x sitting in the middle of that range. The PS ratio has declined from levels above 7.5x in late 2024 and early 2025 to the current 1.89x, reflecting both the stock price decline and revenue growth, placing it near the bottom of its historical band. This compression suggests the market has significantly de-rated the stock, potentially creating a value opportunity if fundamentals stabilize, though it could also reflect justified concerns about long-term growth prospects in the IT services industry.
PE
18.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~21x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Cognizant's financial risks are primarily centered on margin compression and cash flow volatility. Gross margin has fallen from 33.87% in Q3 2025 to 29.63% in Q1 2026, a 424 basis point decline that, if sustained, could reduce annual EPS by roughly $0.50-$0.70 based on the current revenue run rate. Additionally, Q1 2026 free cash flow was only $198 million due to a $730 million acquisition and a $705 million working capital outflow, highlighting the seasonal and acquisition-related cash demands. While the debt-to-equity ratio of 0.105 and interest coverage of 116.7x provide a cushion, the company's reliance on offshore delivery exposes it to wage inflation and currency fluctuations, which could further pressure margins. The dividend payout ratio of 27.35% is manageable, but any earnings decline could jeopardize the 1.53% yield.
Market and competitive risks are significant given Cognizant's premium valuation relative to its growth prospects. The trailing PE of 18.20x is modest, but the forward PE of 9.49x implies the market expects a substantial earnings rebound; if that fails to materialize, multiple compression could drive the stock toward its 52-week low of $37.08. The IT services sector is highly competitive, with Accenture, Infosys, and TCS aggressively pursuing digital transformation deals, and Cognizant's mid-single-digit growth (5.83% YoY) lags some peers. Regulatory headwinds, such as changes to visa policies for skilled workers, could increase costs, while a broader economic slowdown could reduce discretionary IT spending. The beta of 0.83 suggests the stock is less volatile than the market, but it also means it may underperform in strong rallies, as evidenced by the 31.17% relative underperformance over the past year.
The worst-case scenario for Cognizant would be a combination of accelerating margin erosion, a slowdown in large deal wins, and a recession that curbs IT spending. In this scenario, the stock could retest its 52-week low of $37.08, representing a 38.2% decline from the current price of $60.00. The analyst low target of $42.00 implies a 30% downside, and the maximum drawdown of -55.33% over the past period shows the stock's capacity for severe declines. If gross margins fall below 28% and revenue growth decelerates to low single digits, the forward EPS estimate of $6.26 would likely be revised downward, triggering a sell-off that could push the stock below $40. Investors could lose 30-38% from current levels in this adverse scenario.
FAQ
The most severe risk is margin compression: gross margin has fallen from 33.87% in Q3 2025 to 29.63% in Q1 2026, a 424 basis point decline that threatens the earnings recovery needed to justify the forward PE. Second, competitive pressures from Accenture, Infosys, and TCS could lead to market share loss and pricing pressure, especially in digital transformation deals. Third, macroeconomic sensitivity: with a beta of 0.83, the stock is less volatile than the market, but a recession could reduce IT spending, particularly in financial services and healthcare, which together account for over 60% of revenue. Fourth, cash flow volatility: Q1 2026 free cash flow was only $198 million due to acquisition and working capital outflows, highlighting potential liquidity strains. These risks are ranked from most to least severe, with margin compression being the primary concern.
Our 12-month forecast for CTSH includes three scenarios: a bull case (25% probability) with a target range of $75-$84, driven by margin recovery and AI deal wins; a base case (55% probability) with a target range of $60-$68, assuming stable mid-single-digit growth and gradual margin improvement; and a bear case (20% probability) with a target range of $37-$45, triggered by continued margin erosion and a revenue slowdown. The base case is most likely, with the key assumption that gross margins stabilize at 30-31% and revenue grows 5-6% YoY. The analyst average target of $64.18 aligns with our base case, implying 6.97% upside. However, the wide target range ($42-$84) reflects significant uncertainty, and the stock could remain range-bound until there is clearer evidence of margin stabilization.
CTSH appears undervalued on a forward earnings basis but fairly valued relative to its growth prospects. The forward PE of 9.49x is well below the trailing PE of 18.20x, implying the market expects EPS to more than double to $6.26. The price-to-sales ratio of 1.89x and EV-to-EBITDA of 9.49x are also below sector medians, suggesting the stock is cheap relative to peers. However, the PEG ratio of 20.57 is anomalously high, reflecting the depressed trailing earnings base. Compared to its own history, the PS ratio has declined from above 7.5x in late 2024 to 1.89x, near multi-year lows. The market is pricing in limited growth expectations and margin concerns, so if Cognizant can stabilize margins and deliver on earnings, the stock could re-rate higher. Conversely, if growth stalls, the current valuation may be justified.
From a risk/reward perspective, CTSH is a moderate buy for value-oriented investors with a long time horizon. The stock trades at a forward PE of 9.49x, a significant discount to the broader market, and offers 6.97% upside to the analyst average target of $64.18. However, the biggest downside risk is a continued decline in gross margins, which have fallen from 33.87% to 29.63% over two quarters, potentially driving the stock toward the analyst low target of $42.00 (30% downside). The company's fortress balance sheet (D/E of 0.105) and consistent free cash flow ($2.47B TTM) provide some safety. For investors comfortable with volatility and a 12-18 month horizon, the risk/reward is favorable, but those seeking near-term gains may find better opportunities elsewhere.
CTSH is better suited for long-term investment (minimum 12-18 months) rather than short-term trading. The stock is in a nascent recovery phase, up 15.01% over three months but still down 14.95% over the past year, and the technical picture suggests a trend reversal in progress that needs confirmation. The beta of 0.83 indicates lower volatility than the market, which may appeal to risk-averse investors but also means it may lag in strong rallies. The dividend yield of 1.53% and consistent buybacks provide income and support, but the earnings visibility is clouded by margin uncertainty. Short-term traders might exploit the $50-$65 range, but the risk of a breakdown below $50 is significant. For long-term investors, the deep value on forward earnings and fortress balance sheet offer a margin of safety, but patience is required as the company works through margin pressures.
